BRAF and ganglioglioma: Although the prevalence of BRAF mutations in low grade gliomas is relatively low [22], BRAFV600E mutations have been consistently reported as genetic driver in gangliogliomas (18-56%), and have been associated with mTORC1 activation [20, 25].